Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Thrombosis and Haemostasis|June 12, 1999
Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarctionC E Dempfle, F Kontny, U AbildgaardEuropean Heart Journal|May 18, 1999
Fibrin monomer antigen: a novel marker of mortality in acute myocardial infarctionF Kontny, C E Dempfle, U AbildgaardJournal of Hepatology|March 1, 1992
Protein C in patients with alcoholic cirrhosis and other liver diseasesH Bell, O R Odegaard, T Andersson, et al.Thrombosis Research|August 15, 1987
A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsP M Sandset, U Abildgaard, M PettersenScandinavian Journal of Haematology|November 1, 1985
Changes in plasma antithrombin (heparin cofactor activity) during intravenous heparin therapy: observations in 198 patients with deep venous thrombosisH A Holm, S Kalvenes, U AbildgaardJournal of Internal Medicine|March 1, 1995
Long-term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?T Dahl, U Abildgaard, P M SandsetFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1984
On the clinical significance of acquired antithrombin deficiencyY Sørum, G F Handeland, U AbildgaardTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 1998
[Venous thromboembolism--incidence and risk factors in Oslo]F Strekerud, A M Johansen, U AbildgaardActa Paediatrica (Oslo, Norway : 1992)|August 1, 1995
Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?A Whitelaw, M C Mowinckel, U AbildgaardScandinavian Journal of Haematology|November 1, 1983
Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated methodG Frantzen Handeland, U Abildgaard, A O AasenPageof 17